Blood, buccal swab and hair follicles are among the most commonly used sources for forensic science, parentage testing and personal identification. A total of 29 patients who have had a sustained engraftment from 15 months to 21.5 years after allogeneic hematopoietic stem cell transplantation (HSCT) without rejection, relapse or chronic GVHD involving oral mucosa were enrolled for a chimerism study. PCR-amplified short tandem repeat analyses were conducted per patient every 3 months for at least three consecutive times. The results for blood were all donor type except one who had a mixed chimerism, 14.5 years after receiving a transplant for lymphoma. As for buccal swab, mixed chimerism ranging from 10 to 96% donor origin was noted for 28 recipients except the one who had mixed chimerism of blood and retained total recipient type. In contrast, hair follicles were 100% recipient type for the entire group. It is concluded that the hair follicle is devoid of adult stem cell plasticity and may serve as a reliable source of recipient's origin when pretransplant DNA fingerprinting or reference DNA is not available for people who have successfully received allogeneic HSCT while in need of a personal identification.
Introduction
Allogeneic BMT or mobilized peripheral blood stem cell transplantation (PBSCT) has been widely accepted as a curative treatment modality for patients with various hematologic malignancies and non-malignant diseases. [1] [2] [3] [4] [5] [6] For any subject who has a history of successful allogeneic BMT or PBSCT, blood is not suitable for personal identification or kinship study because of a conversion to complete donor type. While blood cells become the donor's genotype, other cells remain of recipient origin. Thomas et al., 7 however, first demonstrated direct evidence for a donor bone marrow origin by the presence of Y-bodies in the alveolar macrophages in man. Gale et al. 8 later confirmed a similar origin for hepatic macrophages. Recently, bone marrow and peripheral blood stem cells have been noted to have the potential to 'transdifferentiate' or 'dedifferentiate' into neural, bone, muscular, cartilage, liver, gut, alveolar, buccal, epidermal or endothelial cells, the so-called 'adult stem cell plasticity phenomenon'. [9] [10] [11] [12] [13] [14] The frequency of these exogenous cells is reported between 0.1 and 10% of tissue-specific cells. Tran et al. 15 were the first to report that male bone marrow-derived cells could migrate into the cheek and differentiate into epithelial cells by in situ hybridization with Y and X chromosome probe labeled with 35-sulfur or digoxigenin or labeled fluorescently.
In this study, sequence-specific primer-based PCRamplified short tandem repeat (STR) analysis technique was used to determine the chimerism of different cells from blood, hair follicles and buccal mucosa aiming to acquire a reliable basis for the establishment of a sound protocol for those who are in need of a personal identification or kinship study while having had a successful allogeneic hematopoietic stem cell transplantation (HSCT).
Patients and methods
From January 2006 to February 2007, a total of 29 patients who had received allogeneic HSCT for various hematological malignancies or severe aplastic anemia and remained in complete remission for at least 1 year were invited to participate in this study. Eligibilities for entry were individuals who had received myeloablative pre-transplant conditioning regimens either with high-dose cyclophosphamide (CY)/total body irradiation or busulfan/CY followed by an allogeneic HSCT for at least 12 months without evidence of sustained chronic GVHD involving oral mucosa, or relapse of the underlying disease. Prophylaxis of acute GVHD consisted of short-course methotrexate (MTX) and standard dose of cyclosporine. A written consent was obtained from each of these participants, which was consistent with the regulations of the Medical Ethics Review Board of our institution.
Timing for the patients to be recruited ranged from 15 months to 21.5 years with a median of 8.2 years after transplantation. Six patients had severe aplastic anemia and 23 others had various hematological malignancies including acute or chronic leukemia, myelodysplastic syndrome, lymphoma or multiple myeloma. Fifteen patients were sex matched with their respective donors, while 14 others were not. Twenty-seven patients received HLA-matched sibling donor transplant, while two others were given unrelated HLA-matched transplantation. Two of 16 BMT patients relapsed and were later rescued by PBSCT while 13 others were given de novo PBSCT.
The chimerism study involving blood, hair follicles and buccal swabs was carried out on an outpatient clinic basis. All 29 patients were asked to repeat the study every 3 months for a minimum of three consecutive times. Whole blood was collected in EDTA-coated tubes. Buccal swabs were collected in triplicate from different areas each time for every participant. Before obtaining buccal swab samples, adequate mouth wash with clean water was required and microscopic examination of the swab smears were performed to ensure that the samples were completely free from contamination of blood cells. DNA extraction from whole blood or buccal swab was carried out with the Puregene Kit (Gentra Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. Preparation of hair follicles was modified from a previous report. 16 Briefly, five full-length hairs with roots were plucked from different areas of the scalp. The presence of the hair bulb was visually confirmed. In case of long hairs, they were cut to about 1 cm including the root, and the distal part was discarded. Careful washing was done to minimize the risk of blood contamination by brief rinse in normal saline and collected in a 1.5 ml Eppendorf tube. QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) was used for DNA extraction according to the manufacturer's instructions.
Chimerism study was performed by using the AmpFlSTR Profiler Plus Kit (Applied Biosystems, Foster City, CA, USA) to amplify a panel of nine highly polymorphic autosomal unlinked STR loci and an additional gender-determining marker Amelogenin, which allows discrimination of the X and Y chromosomes. All PCR products were separated by capillary electrophoresis on the ABI Prism 310 Genetic Analyzer (Applied Biosystems) and fragment sizes were analyzed with the GeneScan software. The integrals of donor-specific and recipientspecific STR informative peak areas were used for calculation of the donor contribution. 17 
Results
The characteristics and results of all 29 patients are summarized in Table 1 . Among five patients who had acute GVHD, three resolved and two progressed to chronic GVHD. Unique patient number (UPN) 10, a 52-year-old female case of CML relapsed 6 months after first allogeneic BMT from her HLA-matched brother was rescued by a PBSCT from the same donor, had later developed scleroderma-like chronic skin GVHD. As of the date of analysis, she was 11.2 years after the second transplantation and in continuous remission status. UPN 27, a 15-year-old boy with ALL had received an HLA-matched allogeneic PBSCT from his elder sister, suffered from acute GVHD after transplantation, then progressed to chronic GVHD as bronchiolitis obliterans of the lungs.
The STR analyses of blood were 100% donor type for all recipients except UPN 6, who was noted to have mixed chimerism with only 23% donor type 14.5 years after transplantation, yet without evidence of relapse of the underlying malignant lymphoma. In contrast, mixed chimerism of buccal swab was noted on serial studies for 28 recipients with donor's origin ranging from 10 to 96% for the latest analyses except UPN 6, who consistently had total recipient's type. As for the results of hair follicles, they were 100% recipient type for the entire group. A representative case, UPN 10, 11.2 years after a successful second allogeneic PBSCT is shown in Figure 1 to illustrate detailed chimerism analysis of the Amenogenin gene and profiles for three STRs (D8S1179, D21S11, D18S51) of peripheral blood, hair follicles and buccal swab, respectively. The Amenogenin gene is informative for complete donor type of blood since the recipient is a woman (homozygous for X) and the donor a man (XY). Three STRs are also informative by individual peak constellation to further distinguish pre-transplant recipient type of hair follicle from mixed chimerism of buccal swab.
Discussion
PCR-amplified STR analysis has been well established as a standard technique for forensic medicine, 18 parentage testing [19] [20] [21] and confirmation of GVHD or engraftment after HSCT. 22, 23 Blood, hair follicles and buccal swab are the most commonly used cellular sources for these purposes. Challenges, however, arise by using these ready sources for personal identification of individuals who have successfully received allogeneic HSCT because of the potential implication of adult stem cell plasticity after transplantation. FISH has long been the preferred technique for tissue specimens to identify any mixed chimerism. [9] [10] [11] [12] [13] [14] [15] By using FISH technique, Tran et al. 15 were the first to demonstrate the plasticity of human bone marrow stem cells into buccal epithelial cells in vivo in five women with a frequency of Y-positive nuclei in buccal epithelial cells ranging between 4 and 11%, 4-6 years after receiving a transplant from an HLA-identical brother for leukemia. All recipients had buccal cheek scrapings consisting of discrete epithelial cells without contamination by mononuclear cells or macrophages. Thiede et al. 24 in a study using STR analysis on 13 patients receiving allogeneic BMT had alleged that buccal swabs but not mouth wash samples could be used to obtain pre-transplant DNA fingerprints from recipients. Donor DNA content, however, was still evident in the buccal swabs with a median of 21% as compared to 74% in the mouthwash samples. They concluded that as mouthwash DNA usually represents a poor source for obtaining a pre-transplantation profile of the recipient, buccal swab DNA can be used for this purpose in the majority of the cases. On the contrary, in the present study, we have noted that mixed chimerism of buccal swabs was evident on all consecutive studies for 28 out of the 29 recipients, whose donor origin ranged from 10 Figure 1 Representative results of the DNA/STR study 11.2 years after a successful second allogeneic PBSCT from the HLA-matched brother to a female patient (UPN 10) with chronic myelocytic leukemia. The numbers below each STR stand for different alleles in number of repeated motifs. Peripheral blood is of donor origin, hair follicle is of recipient type and buccal swab is of mixed chimerism. STR, short tandem repeat.
to 96% (median, 63%). One exception is UPN 6, who remained free of relapse 14.5 years after transplantation and maintained 100% recipient origin of buccal swab but only 23% donor chimerism in blood that might impede adult stem cell plasticity. Further study with recruitment of more cases may answer this question. Literature review has shown that only one study used STR analyses to investigate the role of the donor hematopoietic stem cell for the regrowth of hair after HSCT and demonstrated that there was no evidence of plasticity in hair follicles of recipients. 16 In our study, the STR analyses of hair follicles for the 29 HSCT recipients were all 100% recipient type 1-21.5 years after transplantation. In summary, our findings confirm that hair follicles are devoid of adult stem cell plasticity and remain recipient's origin more than 20 years after allogeneic HSCT. Buccal swab, on the other hand, is always of mixed chimerism and blood has been converted to complete donor type with very rare exception. It is, therefore, concluded that the hair follicle, not buccal swab, is a reliable and ready source as complete recipient origin when pretransplant DNA fingerprints or reference DNA are not available for people who have successfully received allogeneic HSCT. In addition, PCR-amplified STR analysis is very useful for chimerism study based on its sensitivity, the ease of performance and the independence of sex mismatch between donors and recipients.
